CN102319339B - Chinese medicinal composition for treating senile fracture - Google Patents
Chinese medicinal composition for treating senile fracture Download PDFInfo
- Publication number
- CN102319339B CN102319339B CN 201110292402 CN201110292402A CN102319339B CN 102319339 B CN102319339 B CN 102319339B CN 201110292402 CN201110292402 CN 201110292402 CN 201110292402 A CN201110292402 A CN 201110292402A CN 102319339 B CN102319339 B CN 102319339B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese
- medicinal composition
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a Chinese medicinal composition for treating senile fracture. The Chinese medicinal composition is characterized by consisting of the following Chinese herbal medicines in part by weight: 8 to 12 parts of Himalayan teasel root, 8 to 12 parts of Chinese taxillus twig, 8 to 12 parts of eucommia bark, 8 to 12 parts of pyrite, 4 to 8 parts of notoginseng root, 8 to 12 parts of cinnamomvine, 8 to 12 parts of Chinese angelica, 10 to 20 parts of Chinese wolfberry, 3 to 8 parts of macaque bone, 4 to 8 parts of liquoric root, 8 to 12 parts of malaytea scurfpea fruit, 8 to 12 parts of fortune's drynaria rhizome and 15 to 25 parts of heterophylly falsestarwort root. The Chinese medicinal composition for treating senile fracture has a good curative effect, high cure rate and few side effects by combining a treatment method for replenishing qi and blood, tonifying liver and kidney and strengthening muscles and bones and fulfills the treatment aim of restoring physiological functions of human bodies, and the total effective rate is 96.9 percent.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of senile fracture, belong to the field of Chinese medicines.
Background technology
Fracture, the integrity of bone or seriality are damaged caused, the disease take pain, swelling, livid purple, dysfunction, deformity and bony crepitus etc. as main manifestations.
The treatment by oral administration of medicines of the traditional Chinese medical science after to fracture be divided into early, in, rear three phases determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, adopt respectively attack accordingly and, mend three large method for the treatment of.Firm when injured human body the damage of QI and blood is arranged, control blood during treatment and regulate the flow of vital energy and take into account, the method treatments such as eliminating blood stasis by catharsis commonly used, promoting flow of QI and blood, clearing away heat and cooling blood represent prescription and restore blood activating decoction: Radix Bupleuri, Radix Angelicae Sinensis, Flos Carthami, Squama Manis, Radix et Rhizoma Rhei (stir-fried with wine), wine Semen Persicae, Radix Trichosanthis.Damage mid-term, the stasis of blood is not gone to the greatest extent, muscles and bones does not connect, should adopt and method, take promoting regeneration of tissue by regulating nutrient QI, reunion of bone as main, adopt the method treatments such as relieving pain by regulating nutrient QI, reunion of bone, relaxing muscles and tendons and activating QI and blood in the collateral, representing prescription is Jie Gu Zhijindan: Eupolyphaga Seu Steleophaga, Olibanum, Myrrha, Pyritum, Rhizoma Drynariae, Radix Et Rhizoma Rhei, Sanguis Draxonis, Borax Radix Angelicae Sinensis etc.; Blood-activating bone-resetting soup: Radix Angelicae Sinensis, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Radix Rehmanniae, Flos Carthami, Rhizoma Drynariae, Eupolyphaga Seu Steleophaga, Pyritum (calcined), Radix Dipsaci, Herba sambuci chinensis, Olibanum, Myrrha etc.In the damage later stage, the QI and blood loss mostly is virtual image, adopts reinforcement, benefiting qi and nourishing blood commonly used, liver and kidney tonifying method, and representing prescription is decoction of ten powerful tonics: Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae Preparata, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, the Radix Astragali, Cortex Cinnamomi; Chien pu hu chien wan: Cornu Cervi, Colla Plastri Testudinis, Radix Polygoni Multiflori, Radix Cyathulae, the Cortex Eucommiae, Herba Cynomorii etc.
The traditional Chinese medical science is thought, because old people's deficiency of the liver and kindey, muscles and bones is weak, and Whole Body Bone Scanning ilium amount reduces, and sclerotin is compared obviously loose with between twenty and fifty people, and it is slow to repair behind the bones and muscles injury.Therefore the treatment of senile fracture should be take liver and kidney tonifying, QI and blood regulating, reunion of bone as main.
Summary of the invention
Purpose of the present invention be exactly to provide a kind of have better curative effect, in conjunction with the Chinese medicine composition of the method for the treatment of of invigorating the liver and kidney, replenishing QI and blood and bone and muscle strengthening treatment senile fracture.
The present invention is achieved in that the crude drug by following weight portion forms, and all has good therapeutic effect: 8-12 parts of Radix Dipsacis, parasitic 8-12 parts, 8-12 parts of the Cortexs Eucommiae, 8-12 parts of Pyritums, 4-8 parts in Radix Notoginseng, 8-12 parts on mountain, bosom, 8-12 parts of Radix Angelicae Sinensis, 10-20 parts of Fructus Lyciis, 3-8 parts in Shen bone, 4-8 parts in Radix Glycyrrhizae, 8-12 parts of Fructus Psoraleaes, 8-12 parts of Rhizoma Drynariae, 15-25 parts of Radix Pseudostellariaes.
The weight portion of preferred each crude drug is: 10 parts of Radix Dipsacis, parasitic 10 parts, 10 parts of the Cortexs Eucommiae, 10 parts of Pyritums, 6 parts in Radix Notoginseng, 10 parts on mountain, bosom, 10 parts of Radix Angelicae Sinensis, 15 parts of Fructus Lyciis, 5 parts in Shen bone, 6 parts in Radix Glycyrrhizae, 10 parts of Fructus Psoraleaes, 10 parts of Rhizoma Drynariae, 20 parts of Radix Pseudostellariaes.
Preparation technology uses " specification requirement of new Chinese medicine Study on Preparation " in principle, the effective constituent that mainly contains that uses modern new agent technology to extract medicine is used as medicine, add some accessory substances, such as water, sugar, starch etc., can be made into capsule, electuary, tablet, oral liquid.
When this Chinese medicine composition was decocted in water for oral dose, every part was adopted gram to be unit, every day potion, decocting divides secondary oral, be 1 month the course for the treatment of, can reach the clinical cure effect.
The present invention treats senile fracture in conjunction with the Therapeutic Method of replenishing QI and blood, invigorating the liver and kidney and bone and muscle strengthening, and curative effect is better, and cure rate is high, and few side effects makes the physiological function of human body be resumed treatment purpose, and total effective rate is 96.9%.
The specific embodiment
The present invention is described further by clinical observation test and embodiment.
Test example 1, clinical observation on the therapeutic effect data.
The treatment clinical method of senile fracture is a lot of, there is no definite curative effect.We adopted the present invention to treat one group of case in nearly 3 years, obtained preferably curative effect, now reported as follows.
1, clinical data.
1.1 physical data: this group amounts to 107 routine senile fracture patients and is my Out-patient Department and inpatient, male 57 examples wherein, women 50 examples, 61～92 years old age.Diagnostic criteria with reference to " new Chinese medicine guideline of clinical investigations " traditional Chinese medical science disease deficiency of qi and blood and caused by liver and kidney deficiency.At random all cases are divided into two groups, treatment group 64 examples, male 35 examples, women 29 examples; Matched group 43 examples, male 22 examples, women 21 examples; Two groups of patients learn processing by statistics at aspects such as sex, age, the course of disease, the state of an illness, and the difference nonsignificance has comparability.
1.2 Therapeutic Method: this is organized 107 routine patients and all adopts the bonesetting of traditional Chinese medical science traditional method, and maneuver is corrected wrong bone to pull out, to stretch as main simultaneously in maneuver, and plintlet or Gypsum Fibrosum are fixing outward, or the bone traction.Matched group does not give the medicine of any promotion union of fracture, treats that it recovers naturally; Treatment group is take replenishing QI and blood, invigorating the liver and kidney and bone and muscle strengthening as method for the treatment of.Prescription adjusts accordingly in following scope endogenous cause of ill symptom: 8-12 parts of Radix Dipsacis, parasitic 8-12 parts, 8-12 parts of the Cortexs Eucommiae, 8-12 parts of Pyritums, 4-8 parts in Radix Notoginseng, 8-12 parts on mountain, bosom, 8-12 parts of Radix Angelicae Sinensis, 10-20 parts of Fructus Lyciis, 3-8 parts in Shen bone, 4-8 parts in Radix Glycyrrhizae, 8-12 parts of Fructus Psoraleaes, 8-12 parts of Rhizoma Drynariae, 15-25 parts of Radix Pseudostellariaes.
Continuous use 1 month.During treating, encourage two groups of patients to carry out suitable functional exercise, to increase local blood circulation, utilize the contractility of muscle on the limbs longitudinal axis, two fracture ends are combined closely etc.
1.3 curative effect determinate standard is according to disease curative effect determinate standard evaluation in " guideline of clinical investigations of new Chinese medicine treatment traumatic fracture " in the Ministry of Public Health " new Chinese medicine guideline of clinical investigations ".
1. produce effects: transference cure or disease integration reduce 〉=70%; 2. effective: symptom takes a turn for the better or the disease integration reduces 〉=30%,＜70%; 3. invalid: as not reach above standard person.
1.4 statistical method adopts t check and ⅹ
2Check.
2, result.
Two groups of patient clinical curative effects compare, produce effects 27 examples in treatment group 64 examples, and effective 35 examples, invalid 2 examples, total effective rate is 96.9%; Produce effects 6 examples in matched group 43 examples, effective 18 examples, invalid 19 examples, total effective rate 55.8%.Epidemiological Analysis by statistics, there are extremely significant difference (P＜0.01) in treatment group and matched group at clinical efficacy.
The present invention can conduct further description the present invention by the following examples by the technology contents implementation that illustrates in the summary of the invention, yet scope of the present invention is not limited to following embodiment.
Embodiment 1: the crude drug of getting each composition weight portion is: 10 parts of Radix Dipsacis, parasitic 10 parts, 10 parts of the Cortexs Eucommiae, 10 parts of Pyritums, 6 parts in Radix Notoginseng, 10 parts on mountain, bosom, 10 parts of Radix Angelicae Sinensis, 15 parts of Fructus Lyciis, 5 parts in Shen bone, 6 parts in Radix Glycyrrhizae, 10 parts of Fructus Psoraleaes, 10 parts of Rhizoma Drynariae, 20 parts of Radix Pseudostellariaes.
Embodiment 2: the crude drug of getting each composition weight portion is: 8 parts of Radix Dipsacis, parasitic 12 parts, 8 parts of the Cortexs Eucommiae, 12 parts of Pyritums, 4 parts in Radix Notoginseng, 12 parts on mountain, bosom, 8 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lyciis, 3 parts in Shen bone, 8 parts in Radix Glycyrrhizae, 8 parts of Fructus Psoraleaes, 12 parts of Rhizoma Drynariae, 15 parts of Radix Pseudostellariaes.
Embodiment 3: the crude drug of getting each composition weight portion is: 12 parts of Radix Dipsacis, parasitic 8 parts, 12 parts of the Cortexs Eucommiae, 8 parts of Pyritums, 8 parts in Radix Notoginseng, 8 parts on mountain, bosom, 12 parts of Radix Angelicae Sinensis, 10 parts of Fructus Lyciis, 8 parts in Shen bone, 4 parts in Radix Glycyrrhizae, 12 parts of Fructus Psoraleaes, 8 parts of Rhizoma Drynariae, 25 parts of Radix Pseudostellariaes.
Embodiment 4: the crude drug of getting each composition weight portion is: 9 parts of Radix Dipsacis, parasitic 8 parts, 9 parts of the Cortexs Eucommiae, 9 parts of Pyritums, 5 parts in Radix Notoginseng, 9 parts on mountain, bosom, 11 parts of Radix Angelicae Sinensis, 18 parts of Fructus Lyciis, 6 parts in Shen bone, 7 parts in Radix Glycyrrhizae, 9 parts of Fructus Psoraleaes, 11 parts of Rhizoma Drynariae, 22 parts of Radix Pseudostellariaes.
Claims (2)
1. a Chinese medicine composition for the treatment of senile fracture is characterized in that it is comprised of the crude drug of following weight portion: 8-12 parts of Radix Dipsacis, parasitic 8-12 parts, 8-12 parts of the Cortexs Eucommiae, 8-12 parts of Pyritums, 4-8 parts in Radix Notoginseng, 8-12 parts on mountain, bosom, 8-12 parts of Radix Angelicae Sinensis, 10-20 parts of Fructus Lyciis, 3-8 parts in Shen bone, 4-8 parts in Radix Glycyrrhizae, 8-12 parts of Fructus Psoraleaes, 8-12 parts of Rhizoma Drynariae, 15-25 parts of Radix Pseudostellariaes.
2. a kind of Chinese medicine composition for the treatment of senile fracture according to claim 1 is characterized in that the weight portion of each crude drug is: 10 parts of Radix Dipsacis, parasitic 10 parts, 10 parts of the Cortexs Eucommiae, 10 parts of Pyritums, 6 parts in Radix Notoginseng, 10 parts on mountain, bosom, 10 parts of Radix Angelicae Sinensis, 15 parts of Fructus Lyciis, 5 parts in Shen bone, 6 parts in Radix Glycyrrhizae, 10 parts of Fructus Psoraleaes, 10 parts of Rhizoma Drynariae, 20 parts of Radix Pseudostellariaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110292402 CN102319339B (en) | 2011-09-29 | 2011-09-29 | Chinese medicinal composition for treating senile fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110292402 CN102319339B (en) | 2011-09-29 | 2011-09-29 | Chinese medicinal composition for treating senile fracture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102319339A CN102319339A (en) | 2012-01-18 |
| CN102319339B true CN102319339B (en) | 2013-03-13 |
Family
ID=45447264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110292402 Expired - Fee Related CN102319339B (en) | 2011-09-29 | 2011-09-29 | Chinese medicinal composition for treating senile fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102319339B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102813901B (en) * | 2012-08-27 | 2014-03-12 | 陈春英 | Preparation method of traditional Chinese medicine lotion for treating insomnia type closed fractures |
| CN106266247A (en) * | 2016-11-14 | 2017-01-04 | 钱建荣 | A kind of compositions being applicable to treat lumbago |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703692A (en) * | 2009-11-05 | 2010-05-12 | 卢速江 | Chinese medicinal preparation for treating bone fracture and preparation method thereof |
-
2011
- 2011-09-29 CN CN 201110292402 patent/CN102319339B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703692A (en) * | 2009-11-05 | 2010-05-12 | 卢速江 | Chinese medicinal preparation for treating bone fracture and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张世芳，等.中西医结合诊治老年人骨质疏松性骨折的研究进展.《陕西中医学院学报》.2010,第33卷(第6期),第145-147页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102319339A (en) | 2012-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN103006951B (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
| CN101485836A (en) | Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof | |
| CN101249220A (en) | Oral capsule for curing cervicobrachia, lumbodynia and leg pain and method of preparing the same | |
| CN103393840A (en) | Traditional Chinese medicine composition for treating osteoarthritis | |
| CN103393879A (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency | |
| CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
| CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN105250890A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
| CN108159125A (en) | A kind of external medicine composition and its preparation method and application of expelling wind and clearing away cold, promoting blood circulation and stopping pain | |
| CN104013769A (en) | Traditional Chinese medicine oral solution for treating osteoporosis | |
| CN102319339B (en) | Chinese medicinal composition for treating senile fracture | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN103446502A (en) | Traditional Chinese medicine for treating solar dermatitis | |
| CN101537069A (en) | Chinese medicinal preparation for treating erythromelalgia | |
| CN103721237A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
| CN102512560A (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN102349949B (en) | Traditional Chinese medicine ischium pain-relieving decoction for treating sciatica | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN105267630A (en) | Traditional Chinese medicine for treating tinnitus | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN104173934A (en) | Traditional Chinese medicine composition for treating sciatica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 344000 Fuzhou Hospital of traditional Chinese medicine, No. 240, Da Dao, Jiangxi, Fuzhou Patentee after: Li Hong Address before: 315032 1956 creative zone, transformer factory, Nanjing Road, Jiangbei District, Zhejiang, Ningbo Patentee before: Li Hong |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130313 Termination date: 20150929 |
|
| EXPY | Termination of patent right or utility model |